Strikingly, oral treatment with STmΔaroA/ΔansB negated this intrinsic tumour control, as evidenced by expression of Lgr5, Smoc2, and Vim, to levels comparable to the PBS control group, in contrast to the STmΔaroA treatment, which reduces expression of these genes. Here, SMOC2 is linked to neoplasm.